Limit Ranibizumab Injections in Macular DegenerationLimit Ranibizumab Injections in Macular Degeneration

Investigators have identified an optimum number of injections of the vascular endothelial growth factor inhibitor for wet age-related macular degeneration in the first year of treatment. Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Ophthalmology News Source Type: news